Search

Author/Creator Walewski, J.

1. MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCE. (June 2017)

Authors:
Ribrag, V.; Feugier, P.; Doorduijn, J.; Delfau‐Larue, M.; Hermine, O.; Kluin‐Nelemans, H.; Dasilva, M.; Lopez‐Hernandez, A.; Walewski, J.; Szymczyk, M.; Pott, C.; Homburg, C.; Van der Velden, V.; Gameiro, P.; Garcia‐Sanz, R.; Ladetto, M.; van Krieken, H.; Cabeçadas, J.; Rymkiewicz, G.; Klapper, W.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8). (12th June 2019)

Authors:
Paszkiewicz‐Kozik, E.; Michalski, W.; Taszner, M.; Knopińska‐Posłuszny, W.; Mordak‐Domagała, M.; Najda, J.; Borawska, A.; Romejko‐Jarosińska, J.; Chełstowska, M.; Świerkowska, M.; Dąbrowska‐Iwanicka, A.; Malenda, A.; Druzd‐Sitek, A.; Konecki, R.; Kuniega, B.; Osowiecki, M.; Ostrowska, B.; Szpila,...
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PRIMARY BREAST DIFFUSE LARGE B‐CELL LYMPHOMA. CLINICAL FEATURES AND OUTCOME IN 55 PATIENTS. POLISH LYMPHOMA RESEARCH GROUP STUDY. (12th June 2019)

Authors:
Romejko‐Jarosinska, J.; Paszkiewicz‐Kozik, E.; Sokołowska‐Drozd, J.; Waszczuk‐Gajda, A.; Kotarska, M.; Blamek, S.; Kulma‐Kreft, M.; Kurczab, P.; Kumiega, B.; Sawczuk, W.; Zaucha, J.; Walewski, J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
450
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. MOLECULAR ANALYSES AND AN INNOVATIVE DIAGNOSTIC ALGORITHM IN MYC‐NEGATIVE BURKITT‐LIKE LYMPHOMA WITH 11Q ABERRATION: A SINGLE INSTITUTION EXPERIENCE. (12th June 2019)

Authors:
Rymkiewicz, G.; Zajdel, M.; Paziewska, A.; Blachnio, K.; Grygalewicz, B.; Woroniecka, R.; Dabrowska, M.; Bystydzienski, Z.; Romejko‐Jarosinska, J.; Kulecka, M.; Kulinczak, M.; Sromek, M.; Rygier, J.; Borysiuk, A.; Pienkowska‐Grela, B.; Czyz‐Domanska, K.; Miloszewska, J.; Szafron, L.; Prochorec‐So...
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
190
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION. (12th June 2019)

Authors:
Romejko‐Jarosinska, J.; Paszkiewicz‐Kozik, E.; Popławska, L.; Targonski, L.; Szymanski, M.; Walewski, J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. AUTOLOGOUS STEM CELL TRANSPLANT WITH HIGH DOSE MELPHALAN PREPARATIVE REGIMEN IS SAFE AND EFFECTIVE FOR ELDERLY MULTIPLE MYELOMA PATIENTS IN THE ERA OF TRIPLE INDUCTION THERAPY. (12th June 2019)

Authors:
Czyz, A.; Romejko‐Jarosinska, J.; Szeremet, A.; Bogucka‐Fedorczuk, A.; Majcherek, M.; Szymanski, M.; Walewski, J.; Wrobel, T.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
549
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A NEW BCL‐2 INHIBITOR (S55746/BCL201) AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMA: PRELIMINARY RESULTS OF THE FIRST‐IN‐HUMAN STUDY. (June 2017)

Authors:
Le Gouill, S.; Wermke, M.; Morschhauser, F.; Lim, S.T.; Salles, G.; Kloos, I.; de Burgat, V.; Becquart, M.; Paux, G.; Kraus‐Berthier, L.; Pennaforte, S.; Stilgenbauer, S.; Walewski, J.; Ribrag, V.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. RESPONSE BY STAGE IN CD30‐POSITIVE (CD30+) CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS RECEIVING BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN THE PHASE 3 ALCANZA STUDY. (June 2017)

Authors:
Horwitz, S.; Whittaker, S.; Duvic, M.; Dummer, R.; Kim, Y.H.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.; Wolter, P.; Eradat, H.; Sanches, J.; Ortiz‐Romero, P.; Akilov, O.; Trotman, J.; Taylor, K.; Dalle, S.; Weichenthal, M.; Walewski, J.; Fisher, D.; Wang, Y.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
245
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE ALONE AFTER STEM-CELL TRANSPLANT FOR MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Kubicki, T.; Robak, P.; Walter-Croneck, A.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; Szczepaniak, T.; Łojko-Dankowska, A.; Matuszak, M.; Gil, L.; Puła, B.; Rybka, J.; Majcherek, M.; Usnarska-Zubkiewicz, L.; Szukalski, L.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA. (23rd June 2022)

Authors:
Wang, M. L.; Jurczak, W.; Jerkeman, M.; Trotman, J.; Zinani, P. L.; Belada, D.; Boccomini, C.; Flinn, I. W.; Giri, P.; Goy, A.; Hamlin, P. A.; Hermine, O.; Hernández-Rivas, J.-Á.; Hong, X.; Kim, S. J.; Lewis, D.; Mishima, Y.; Özcan, M.; Perini, G. F.; Pocock, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗